|
|
|
|
| Donald C. Arbitblit |
| Partner |
| San Francisco |
|
| Practice Areas Include: |
Environmental
and Toxic Torts
Personal Injury/Torts |
|
|
|
|
|
|
| Bar Information |
| |
Admitted
to practice in Vermont, 1979; California and U.S. District Court,
Northern District of California, 1986. |
|
|
| Education |
| |
Boalt Hall School of Law, University of
California (J.D., 1979); Order of the Coif; Tufts University (B.S., magna
cum laude, 1974). |
|
|
| Publications |
| |
Co-Author with Wendy Fleishman, "The
Risky Business of Off-Label Use," Trial (March 2005); “Comment
on Joiner: Decision on the Daubert Test of Admissibility
of Expert Testimony,” 6 Mealey’s Emerging Toxic Torts,
No. 18 (December 1997); Co-author with William Bernstein, “Effective
Use of Class Action Procedures in California Toxic Tort Litigation,” 3 Hastings
West-Northwest Journal of Environmental Law and Policy, No. 3
(Spring 1996); “The Plight of American Citizens Injured by Transboundary
River Pollution,” 8 Ecology Law Quarterly, No. 2 (1979). |
|
|
| Awards |
| |
"Northern California Super Lawyer," Law & Politics,
2004, 2006, 2007. |
|
|
| Member |
| |
Member of the Federal Court-appointed Science
Executive Committee, and Chair of the Epidemiology/Clinical Trials
Subcommittee, In re Vioxx Products Liability Litigation, MDL
No. 1657 (E.D. La.); Federal Science and Expert Witness Committees
in In re Diet Drugs (Phentermine/Fenfluramine/ Dexfenfluramine)
Products Liability Litigation, MDL No. 1203 (E.D. Pa.), In re
Baycol Products Litigation, MDL No. 1431 (D. Minn.) and Rezulin
Products Liability Litigation, MDL No. 1348 (S.D.N.Y.); Bar Association
of San Francisco; State Bar of California. |
|
|
|
|
|
|
Lieff
Cabraser Heimann & Bernstein, LLP
|
|
|
|
|
|
|
|
|
Copyright © 2007 Lieff Cabraser Heimann & Bernstein, LLP |
|
|
|
|
Merck
Agrees to Resolve U.S. VIOXX® Product Liability
Lawsuits
November 9, 2007
Merck & Co., Inc. announced that it has entered into an agreement to resolve
state and federal myocardial infarction (MI) and ischemic stroke claims already
filed against the Company in the United States. More... |
|
|
|
|